Wealth Alliance Advisory Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Wealth Alliance Advisory Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,600	Closed	-$291K	–	175
2021 Q4	$291K	Hold	2,600	–	–	0.13%	124
2021 Q3	$327K	Hold	2,600	–	–	0.16%	101
2021 Q2	$352K	Hold	2,600	–	–	0.17%	102
2021 Q1	$353K	Hold	2,600	–	–	0.18%	92
2020 Q4	$366K	Sell	2,600 -115	-4%	-$14.7K	0.2%	83
2020 Q3	$303K	Sell	2,715 -270	-9%	-$30.3K	0.18%	85
2020 Q2	$334K	Sell	2,985 -200	-6%	-$19.7K	0.2%	73
2020 Q1	$247K	Hold	3,185	–	–	0.19%	87
2019 Q4	$303K	Sell	3,185 -1,000	-24%	-$86.5K	0.17%	88
2019 Q3	$323K	Buy	4,185 +725	+21%	+$60.3K	0.2%	78
2019 Q2	$298K	Sell	3,460 -195	-5%	-$16.6K	0.18%	86
2019 Q1	$310K	Buy	3,655 +510	+16%	+$43.4K	0.2%	81
2018 Q4	$226K	Sell	3,145 -6,874	-69%	-$554K	0.17%	98
2018 Q3	$961K	Buy	10,019 +515	+5%	+$49.9K	0.49%	43
2018 Q2	$905K	Sell	9,504 -1,625	-15%	-$149K	0.5%	41
2018 Q1	$976K	Buy	+11,129	New	+$1.02M	0.57%	38

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Wealth Alliance Advisory Group's XBI Position: Q1 2022 in Review

Wealth Alliance Advisory Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 2,600 shares — an estimated $291K sold.

Wealth Alliance Advisory Group first reported a position in XBI in Q1 2018 and held it in 16 quarters. The position peaked at $976K in Q1 2018. 702 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

Wealth Alliance Advisory Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
Wealth Alliance Advisory Group sold 2,600 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $291K.
Wealth Alliance Advisory Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and held it in 16 quarters.
Wealth Alliance Advisory Group's State Street SPDR S&P Biotech ETF position peaked at $976K in Q1 2018.
702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Wealth Alliance Advisory Group's 13F filing for Q1 2022, filed 18 Apr 2022.